Barbara Berglund

Newsletter | February 5, 2020 Sponsor Enabling Vaccine Production: Solving Challenges Together Efficient and cost-effective manufacturing of vaccines is one of the toughest problems in the life sciences. We actively collaborate with academia, vaccine researchers, and manufacturers to develop and optimize innovative tools, processes, and strategies to resolve bottlenecks and accelerate the availability of vaccines.

By Barbara Berglund, COO, CMC Turnkey Solutions There are so many factors that figure into initial selection of a CDMO; you would consider capabilities, core competency, schedule flexibility, quality, and regulatory track record. Perhaps the largest focus, or at least the greatest pressure, comes from the financial aspect of CDMO selection.

By Barbara Berglund, COO, CMC Turnkey Solutions The applications of nanotechnology in medicine and disease treatment are far-reaching and exciting. Targeting diseases and organs, providing vehicles for unstable medicines, and providing innovative therapies are a few examples of these applications.